Close Menu

Cleveland Clinic

The partners will use Watson's cognitive capabilities to reduce to minutes from weeks the translation of DNA information to create a genetic profile of a patient.

Besides optimizing open-source code, the company has forged focused partnerships with multiple bioinformatics firms including Edico Genome and Curoverse. 

NEW YORK (GenomeWeb) – IBM said today that it has partnered with the Cleveland Clinic to evaluate the use of its Watson supercomputer in a personalized oncology program at the clinic.

NEW YORK (GenomeWeb) – Cleveland Clinic and University Hospitals have received a $1 million donation to support genome sequencing for cancer patients across the Northeast Ohio region.

A team comprising researchers from Genomic Health and the Cleveland Clinic have published a study describing the analytical validation of Oncotype DX prostate, the company's RT-PCR-based gene expression assay intended to predict prostate cancer aggressiveness and severity from fi

The Cleveland Clinic is beginning a study to assess the feasibility and clinical impact of using targeted sequencing, provided by Foundation Medicine, to guide cancer care for patients with a variety of solid tumors.

The Cleveland Clinic is a month into a pilot program to test whether electronic health record alerts can serve as an effective way to integrate pharmacogenetic-informed prescribing into standard clinical practice.

PHOENIX (GenomeWeb News) – Whole-exome sequencing is inching its way into the clinic, and at the American College of Medical Genetics and Genomics annual meeting held here geneticists and clinicians showed how such sequencing could be used to find diagnoses for patients whose conditions had remai

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute has awarded grants totaling $22 million to five institutions to conduct metabolomics research into cardiovascular and lung diseases.

By Molika Ashford
Cleveland Clinic researchers have launched a 600-patient prospective study evaluating a SNP panel for predicting autism risk developed by French biotech firm IntegraGen.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.